Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HAO | Share Purchase Offer | 18:30 | 19 | 4.8K | |||
|
|||||||
HAO | ASX Re-listing | 31/10/23 | 1 | 522 | |||
|
|||||||
HAO | CAI TH | 23/10/23 | 10 | 1.8K | |||
|
|||||||
HAO | Capital restructure | 27/09/23 | 13 | 3.1K | |||
|
|||||||
HAO | Maybe good things will finally happen? | 21/08/23 | 15 | 3.3K | |||
|
|||||||
HAO | No Buyers | 14/08/23 | 2 | 744 | |||
|
|||||||
HAO | Calidus Announcement June 2023 | 27/06/23 | 3 | 1.1K | |||
|
|||||||
HAO | 2022 AGM | 07/05/23 | 15 | 5.0K | |||
|
See All Discussions